Isoppads

Isoppads

SCHEMBL31722449

Cc1nc(N=Nc2cc(S(=O)(=O)[O-])ccc2S(=O)(=O)[O-])c(COP(=O)([O-])[O-])c(C=O)c1O.[Na+].[Na+].[Na+].[Na+]

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Isoppads. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB known ✓ P10828 2/20 0.63
▸ P2RY4 known ✓ P51582 1/20 0.63
▸ P2RY6 known ✓ Q15077 1/20 0.63
▸ P2RY1 known ✓ P47900 3/20 0.62
▸ MAPT P10636 7/20 0.86
▸ TDP1 Q9NUW8 7/20 0.86
▸ P2RY13 Q9BPV8 4/20 0.86
▸ THPO P40225 2/20 0.86
▸ TSHR P16473 1/20 0.86
▸ KDM4E B2RXH2 5/20 0.69
▸ KMT2A Q03164 5/20 0.69
▸ HPGD P15428 4/20 0.69
▸ MEN1 O00255 3/20 0.69
▸ HSD17B10 Q99714 3/20 0.69
▸ P2RX3 P56373 3/20 0.69
▸ P2RX2 Q9UBL9 2/20 0.69
▸ POLB P06746 3/20 0.63
▸ APEX1 P27695 3/20 0.63
▸ BLM P54132 3/20 0.63
▸ CYP2C19 P33261 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7196936 0.93 MAPT (1.00) MAPTTDP1P2RY13THPOTSHR
SCHEMBL30176649 0.93 MAPT (1.00) MAPTTDP1P2RY13THPOTSHR
Water SCHEMBL30904755 0.92 MAPT (0.98) MAPTTDP1P2RY13THPOTSHR
Isoppads SCHEMBL29494952 0.82 MAPT (1.00) MAPTTDP1P2RY13THPOTSHR
Isoppads SCHEMBL14702227 0.82 MAPT (1.00) MAPTTDP1P2RY13THPOTSHR
SCHEMBL29381820 0.78 MAPT (1.00) MAPTTDP1P2RY13THPOTSHR
SCHEMBL13624677 0.76 MAPT (1.00) MAPTTDP1P2RY13THPOTSHR
SCHEMBL7196945 0.76 MAPT (1.00) MAPTTDP1P2RY13THPOTSHR
SCHEMBL31236767 0.76 MAPT (1.00) MAPTTDP1P2RY13THPOTSHR
SCHEMBL29357199 0.76 MAPT (1.00) MAPTTDP1P2RY13THPOTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025229484-A1 PURINERGIC P2 RECEPTOR ANTAGONISTS FOR USE IN THE TREATMENT OF CONGENITAL SIDEROBLASTIC ANEMIAS UNIVERSITÀ DEGLI STUDI DI BARI ALDO MORO (IT) 2025-11-06 — — WO disclosed
Send feedback